The White House has rolled out TrumpRx, a new government website that promises sharply lower prices on dozens of prescription drugs — a move the White House is hailing as historic, though experts warn ...

Share on Pinterest New GLP-1 ads, like telehealth provider Ro’s new campaign featuring tennis icon Serena Williams, aim to shift the conversation about weight loss drugs. With 127 million pairs of ...

An educational resource published by Grace Point Treatment Center in Fort Lauderdale provides a detailed overview of alcohol use disorder treatment within a structured clinical care setting. The ...

Flyysoulja is taking a major step toward recovery. The Island Boys rapper has checked into rehab months after experiencing a drug-induced psychotic episode. "I'm going to detox right now to get the ...

Americans pay about three times what other wealthy nations do for branded prescription drugs. For years, policymakers have tried to fix this by cutting U.S. drug prices directly. President Trump has ...

Alcohol seems to have lost its grip on American life in recent years. Younger adults are drinking less. Sober bars and alcohol-free member clubs are cropping up across the country. Nonalcoholic beer ...

John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. WASHINGTON — The House and ...

Substance abuse is a serious and growing issue affecting millions of individuals and families around the world. Addiction does not only impact the person using drugs or alcohol—it deeply affects ...

Federal health officials are no longer advising how many alcoholic drinks are safe for Americans, instead urging people to "consume less alcohol" and abstain altogether if they have certain health ...

Thousands of people pause their cocktail consumption and embrace Dry January every year. The percentage of Americans who say they drink alcohol has hit new lows. And more and more, researchers warn we ...

At this point, millions of people in the U.S. have tried at least one of a variety of glucagonlike peptide 1 (GLP-1) receptor agonist drugs such as Zepbound or Wegovy. For some, these medications have ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Birmingham company expects ...